Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Un-Audited Standalone & Consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has informed BSE that its Board of Directors will meet on November 14, 2025, to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the second quarter and half year ended September 30, 2025. The company has also closed its trading window for directors, promoters, designated employees, and connected persons until November 16, 2025. No financial figures or outcomes have been disclosed at this stage — this is a routine advance notice ahead of the results announcement.
No immediate impact on shareholders; investors should watch for the actual results on or after November 14, 2025 for any directional cues on the company's Q2 performance.